In the shadow of coronavirus vaccine development, another vaccine was making solid progress.
By studying elite controllers—people who are able to arrest the progress of HIV without medication—researchers have found a promising new path.
A novel use of bacteria could blunt the spread of dengue and other mosquito-borne diseases.
Puzzling through the cholera antibody response may help slow a disease that affects millions of people every year.
The fledgling field of chronotherapy—timing drugs to a patient’s circadian rhythms—may yet come to the aid of those at risk from the virus.
The idea of having computers design new therapies has slowly been gaining ground. In the COVID-19 crisis, it may have found its moment.
The ascendance of virtual and distanced care has taken place with extraordinary speed. Lee Schwamm discusses which innovations are likely to stick and some bumps in the road ahead.
A novel coronavirus would come to affect every ward, clinician, researcher and patient at Massachusetts General Hospital.
COVID-19 cases are again on the rise. MGH incident commander Ann Prestipino reflects on the road traveled so far and which next steps are critical.
As the first COVID-19 patients arrived, pressure mounted to discover how the disease worked and how it could be beaten back.
No Articles Found.